SCHEMBL5802142

SCHEMBL5802142

CNc1cnc(Cl)cc1-c1ccccc1-c1cc(Cl)ncc1NC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 2/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
GAA P10253 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1869746 0.91 POLB (0.40) KDM4ECYP1A2CYP2C9CYP2D6RAB9A
SCHEMBL1868987 0.90 CYP1A2 (0.46) GPBAR1MAPTKDM4ECYP1A2CYP2C9
SCHEMBL1872528 0.89 LRRK2 (0.40) GPBAR1MAPTKDM4EL3MBTL1GAA
SCHEMBL1875858 0.85 BAZ2B (0.35) GPBAR1MAPTKDM4EL3MBTL1GAA
SCHEMBL1873974 0.84 PTGS1 (0.38) GPBAR1CLK4POLB
SCHEMBL1872947 0.84 IDO1 (0.41) MAPTL3MBTL1PDCD1CD274RAB9A
SCHEMBL1872167 0.81 FEN1 (0.33) GPBAR1PDCD1CD274EGFRMAPK1
SCHEMBL22930015 0.80 GABRP (0.41) GPBAR1MAPTKDM4EL3MBTL1GAA
SCHEMBL1867377 0.80 HSD11B1 (0.40) MAPTKDM4EGAAMEN1ALDH1A1
SCHEMBL1870333 0.77 ALDH1A1 (0.32) CYP2D6CYP3A4ALOX15CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1643998-A1 DUAL NK1/NK3 ANTAGONISTS FOR TREATING SCHIZOPHRENIA F. HOFFMANN-LA ROCHE AG (CH) 2006-04-12 EP disclosed
WO-2005002577-A1 DUAL NK1/NK3 ANTAGONISTS FOR TREATING SCHIZOPHRENIA F. HOFFMANN-LA ROCHE AG (CH) 2005-01-13 WO disclosed